Scancell
SEARCH
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • CLINICAL ADVISORY BOARD
    • PARTNERSHIPS
    • CAREERS
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
    • SCOV1 & SCOV2 (COVIDITY)
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • INVESTORS
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • CLINICAL ADVISORY BOARD
    • PARTNERSHIPS
    • CAREERS
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
    • SCOV1 & SCOV2 (COVIDITY)
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US

Investor Information


 

Scancell Holdings PLC is an AIM listed company 
Advisors
Share Information
Corporate Governance
Financial Information
Documents & Presentations
Regulatory News

Press Releases

Results of AGM 2021

To download click here

November 24, 2021

Introducing Scancell's New Facilities

 

November 24, 2021

First patient dosed in SCIB1 Phase 2 clinical trial

To download click here

November 19, 2021

View all posts »
  • Company
  • Overview
  • Board of Directors
  • Management
  • Clinical Advisory Board
  • Partnerships
  • Technology
  • Immunobody
  • Moditope
  • AvidiMab
  • Scientific Papers & Posters
  • Products
  • Product Pipeline
  • SCIB1
  • SCIB2
  • Modi-1
  • Modi-2
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us
  • Privacy

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2021